Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Risedronate Sodium (NE 58095 Sodium) is an aminobisphosphonate derivative of etidronic acid and CALCIUM CHANNEL BLOCKER that inhibits BONE RESORPTION and is used for the treatment of OSTEOPOROSIS.
説明 | Risedronate Sodium (NE 58095 Sodium) is an aminobisphosphonate derivative of etidronic acid and CALCIUM CHANNEL BLOCKER that inhibits BONE RESORPTION and is used for the treatment of OSTEOPOROSIS. |
In vitro | Risedronate prevents the reduction of periosteal formation and the increase of endocortical bone resorption, thereby preserving the percentage of cortical bone and marrow area. It enhances osteoblast density and lacunar occupancy while preventing the augmentation of cortical bone porosity induced by GCs. Risedronate and Vitamin K(2) exhibit additive effects on bone density and lacunar occupancy and synergistic action against cortical bone porosity. At a dosage of 1 mg/kg in rats, Risedronate significantly increases the volumetric density of bone (Vb) and osteoblasts (Vob) and more notably reduces Vm. In rats, Risedronate dose-dependently and significantly decreases tooth movement following orthodontic force application. |
In vivo | At a concentration of 1 μM, Risedronate reduced the formation of colonies exhibiting osteoblastic characteristics, such as collagen accumulation, alkaline phosphatase expression, and mineralization. Conversely, 1 nM Risedronate and sodium alendronate increased the formation of fibroblast colonies, while not affecting the formation of colonies with osteoblastic traits. Risedronate completely inhibited the formation of fibroblastic colony-forming units in the calcification culture of rat bone marrow cells, whereas etidronate sodium had a comparatively lower effect. Additionally, Risedronate significantly suppressed the expression of c-Fos and nuclear factors in bone marrow-derived macrophages, specifically inhibiting the RANKL-induced activation of T cell clone c1. |
別名 | NE 58095 Sodium, Risedronic Acid Sodium |
分子量 | 305.09 |
分子式 | C7H10NNaO7P2 |
CAS No. | 115436-72-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 10 mM
DMSO: Insoluble
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Risedronate Sodium 115436-72-1 Metabolism Microbiology/Virology HBV Transferase inhibit Risedronic Acid Inhibitor NE 58095 Sodium Risedronic Acid Sodium Risedronate inhibitor